|

   |

Company

Product Spotlight

Patient Resources

In The News

Xoft® is the only FDA cleared electronic brachytherapy (eBx®) system that has been used to treat 3,000 non-melanoma skin
cancer patients & is supported by positive
3-year clinical data.

iCAD is committed to providing advanced cancer detection and treatment options for unparalleled care.

Learn more about CAD technology and Xoft® eBx® for your cancer treatment.

  • SKIN eBx®

    Surgery is not the only option.

    Learn more about eBx® for non-melanoma skin cancer treatment.

  • IORT & APBI

    “I came in with cancer, went to sleep, and when I woke up, I was completely done with my breast cancer treatment.”

    –Marianne, IORT Patient  Learn more.

  • GYN eBx®

    Learn more about GYN eBx® for your gynecological cancer treatment.

  • Computer-Aided Detection (CAD)

    iCAD technology helps physicians and patients in the fight against the most prevalent cancers: breast, colorectal,  and prostate. Learn more about CAD.

3/17/14

iCAD Inc., Announces Closing of Underwritten Public Offering of Common Stock

Read More

3/6/14

iCAD Announces More Than 1,000 Early Stage Breast Cancer Patients Treated With Intraoperative Radiation Therapy (IORT) Using the Xoft® System

Read More

3/5/14

iCAD, Inc. Announces Proposed Public Offering of Common Stock

Read More

View All News & Events »

Privacy Policy   |   Company   |   Investors   |   Contact Us   |   Careers

Copyright © 2014, iCAD Inc.  All rights reserved.   Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.